An open-label, nonrandomized study to evaluate the potential pharmacokinetic interaction between multiple doses of lecozotan SR [sustained release] and a single oral dose of digoxin when administered orally to healthy adult subjects

Trial Profile

An open-label, nonrandomized study to evaluate the potential pharmacokinetic interaction between multiple doses of lecozotan SR [sustained release] and a single oral dose of digoxin when administered orally to healthy adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2010

At a glance

  • Drugs Digoxin; Lecozotan
  • Indications Alzheimer's disease; Arrhythmias; Heart failure
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 08 Sep 2008 Status changed from not yet recruiting to completed as reported by Clinicaltrials.gov.
    • 08 Sep 2008 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
    • 14 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top